MoonLake Immunotherapeuti...

NASDAQ: MLTX · Real-Time Price · USD
53.95
-0.93 (-1.69%)
At close: Aug 15, 2025, 3:04 PM

MoonLake Immunotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-121.24M -44.08M -64.51M -53.64M
Depreciation & Amortization
1.38M 13.16K 12.36K 4.97K
Stock-Based Compensation
7.28M 7.11M 9.65K 10.86K
Other Working Capital
-2M -6.22M -44.8K 3.06M
Other Non-Cash Items
-225.71K 399.51K 372.49K 12.57M
Deferred Income Tax
n/a n/a n/a 1.4M
Change in Working Capital
-3.78M -6.22M -1.43M 4.48M
Operating Cash Flow
-116.59M -42.78M -55.89M -35.18M
Capital Expenditures
-519.52K -284.63K -16.01K -50.71K
Cash Acquisitions
n/a n/a 32.32K n/a
Purchase of Investments
-350.28M -175.73M -42.23M n/a
Sales Maturities Of Investments
145.2M 150.83M 9.9M n/a
Other Investing Acitivies
n/a n/a -32.32K n/a
Investing Cash Flow
-205.6M -25.18M -32.34M -50.71K
Debt Repayment
n/a n/a -15M 15M
Common Stock Repurchased
-50 n/a n/a -6.2K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-1.23M -2.75M 134.69M n/a
Financial Cash Flow
51.31M 479.7M 119.69M 43.26M
Net Cash Flow
-270.74M 411.66M 31.47M 6.7M
Free Cash Flow
-117.11M -43.06M -55.91M -35.23M